These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4291816)

  • 21. Action of vaccinia virus on the reactivity of albino mice inoculated with pertussis vaccine.
    Pozsgi N; David C; Andreescu V; Caffé I; Ghyka G
    Z Immunitatsforsch Exp Klin Immunol; 1971 Aug; 142(2):129-35. PubMed ID: 4105636
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of a ribosomal vaccine against pertussis.
    Field LH; Parker CD; Manclark CR; Berry LJ
    Infect Immun; 1979 May; 24(2):346-51. PubMed ID: 222684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modified state of susceptibility to histamine in mice treated with Bordetella pertussis during the neonatal period.
    Poszgi N; David C; Ghyka G; Marion M; Andreescu V; Caffé I; Olinescu A
    Z Immunitatsforsch Allerg Klin Immunol; 1970 Oct; 140(4):326-34. PubMed ID: 4321232
    [No Abstract]   [Full Text] [Related]  

  • 24. Lung pathology and immediate hypersensitivity in a mouse model after vaccination with pertussis vaccines and challenge with Bordetella pertussis.
    Vandebriel RJ; Gremmer ER; Vermeulen JP; Hellwig SM; Dormans JA; Roholl PJ; Mooi FR
    Vaccine; 2007 Mar; 25(12):2346-60. PubMed ID: 17224216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Toxicity of Bordetella pertussis suspensions associated with the preparation of pertussis vaccine].
    Raĭkher LI; Kalinina ES; Shafran MI; Khazina EKh; Aĭnbinder ZTs
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Mar; (3):15-7. PubMed ID: 6303021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Vaccine from cellular fragments of B. pertussis. II. Toxic properties of the vaccine].
    Shirko GN; Zakharova MS
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Jul; (7):68-74. PubMed ID: 211762
    [No Abstract]   [Full Text] [Related]  

  • 27. Endotoxin-induced hypersensitivity to histamine in mice. I. Contrasting effects of bacterial lipopolysaccharides and the classical histamine-sensitizing factor of Bordetella pertussis.
    Pieroni RE; Broderick EJ; Levine L
    J Bacteriol; 1966 Jun; 91(6):2169-74. PubMed ID: 5943934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [MODEL EXPERIMENTS WITH RADIO-NUCLIDE LABELING OF ANTIBODIES AGAINST BORDETELLA ERTUSSIS].
    OCKLITZ HW; HERZMANN H; WEPPE CM
    Z Immunitats Allergieforsch; 1964 Oct; 127():428-35. PubMed ID: 14329797
    [No Abstract]   [Full Text] [Related]  

  • 29. Interconnexion between the protective antigen and the histamine-sensitizing factor of Bordetella pertussis.
    JOO I; PUSZTAI Z
    Nature; 1960 Oct; 188():331-2. PubMed ID: 13790658
    [No Abstract]   [Full Text] [Related]  

  • 30. Bordetella pertussis-induced alteration of the normal hyperglycemic response of mice to 3',5'-adenosine phosphate.
    Cronholm LS; Fishel CW
    J Bacteriol; 1968 Jun; 95(6):1993-9. PubMed ID: 4299372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxic and reactogenic properties of pertussis bacteria (experimental and clinical studies).
    Demina AA; Semina NA; Trofimova NP; Igonina YA; Gracheva AM
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(3):293-304. PubMed ID: 171306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental acute pulmonary edema in the rat. Effect of Bordetella pertussis vaccine on ozone mortality.
    Thompson GE
    Arch Environ Health; 1971 Aug; 23(2):154-60. PubMed ID: 4326836
    [No Abstract]   [Full Text] [Related]  

  • 33. Histamine-sensitizing factors from microbial agents, with special reference to Bordetella pertussis.
    Munoz J; Bergman RK
    Bacteriol Rev; 1968 Jun; 32(2):103-26. PubMed ID: 4298544
    [No Abstract]   [Full Text] [Related]  

  • 34. Further characterization of Japanese acellular pertussis vaccine prepared in 1988 by 6 Japanese manufacturers.
    Sato Y; Sato H
    Tokai J Exp Clin Med; 1988; 13 Suppl():79-88. PubMed ID: 2908530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attempts at analysis of toxicity of pertussis vaccine. I. Body weight-decreasing toxicity in mice.
    Kurokawa M; Ishida S; Iwasa S; Asakawa S; Kuratsuka K
    Jpn J Med Sci Biol; 1968 Apr; 21(2):137-53. PubMed ID: 4299576
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunobiological properties of Bordetella pertussis].
    Kopacka B
    Pediatr Pol; 1972; 47(3):361-70. PubMed ID: 4336329
    [No Abstract]   [Full Text] [Related]  

  • 37. Enhancement of reaginic and hemagglutinating antibody production by an extract of Bordetella pertussis containing histamine sensitizing factor.
    Lehrer SB; Vaughn JH; Tan EM
    J Immunol; 1976 Jan; 116(1):178-83. PubMed ID: 173756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the histamine-sensitizing factor of Bordetella pertussis by density gradient centrifugation.
    Griffiths BW; Mason MA
    Can J Microbiol; 1968 May; 14(5):525-8. PubMed ID: 4173097
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative biological activities of acellular pertussis vaccines produced by Kitasato.
    Watanabe M; Izumiya K; Sato T; Yoshino K; Nakagawa N; Ohoishi M; Hoshino M
    Kitasato Arch Exp Med; 1991 Apr; 64(1):31-42. PubMed ID: 1798236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histopathological changes in mice treated with extracts of the histamine-sensitizing factor of Bordetella pertussis.
    Lehrer SB; Nakamura RM; Tan EM
    Int Arch Allergy Appl Immunol; 1977; 54(2):129-42. PubMed ID: 193800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.